Leor Lab
Yeshai Schary, PhD student
E-mail: yeshaischary@mail.tau.ac.il
Phone: +972-3-530-8409
​
Yeshai is a PhD student. His research focuses on CRISPR-Cas9-based gene editing of human mesenchymal stromal cells to improve the outcome of cell therapy. He aims to to provide a new strategy to enhance MSC-based cell therapy to improve cardiac remodeling and function in patients who suffer from heart failure.
Publications
-
Schary Y, Naftali-Shani N, and Leor J. CRISPR/Cas9-Based Knockout of the TLR4 gene Enhances Secretion of Extracellular Vesicles With Anti-Inflammatory Properties From Human Cardiac Mesenchymal Stromal Cells. Circulation Research 125.Suppl_1 (2019): A719-A719.
-
Rotem I, Schary Y, Teper O, Konfino T and Leor, J. (2019). P314 Osteopontin stimulates cell cycle in neonatal cardiomyocytes. European Heart Journal. 40. 10.1093/eurheartj/ehz747.0149
-
Cohn Yakubovich D, Sheyn D, Bez M, Schary Y, Yalon E, Sirhan S, Amira M, Yaya A, De Mel S, Da X, Ben-David S, Tawackoli W, J. Ley E, Gazit D, Gazit Z and Pelled G. Systemic administration of mesenchymal stem cells combined with parathyroid hormone therapy synergistically regenerates multiple rib fractures. Stem cell research & therapy. 2017 Dec;8(1):51.
-
Cohn Yakubovich D, Eliav U, Yalon E, Schary Y, Sheyn D, Cook-Wiens G, Sun S, McKenna CE, Lev S, Binshtok AM, G. . Bone. 2017 Apr 1;97:192-200.